Kura Oncology, Inc. (KURA) ownership: insiders 2% · institutions 89% · index and ETF funds 6% (13F 2026-03-31). Insider activity, 90 days: Insiders bought (2 sales, 1 open-market buys). 1 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 9637531.00 | $78.35M | 10.8% | 2026-03-31 |
| Suvretta Capital Management, LLC | 8575422.00 | $69.72M | 9.6% | 2026-03-31 |
| BVF Inc/il | 8445769.00 | $68.66M | 9.5% | 2026-03-31 |
| Vanguard | 5690589.00 | $46.26M | 6.4% | 2026-03-31 |
| State Street | 4511891.00 | $36.68M | 5.1% | 2026-03-31 |
| Armistice Capital, LLC | 3736000.00 | $30.37M | 4.2% | 2026-03-31 |
| Prosight Management, LP | 3356700.00 | $27.29M | 3.8% | 2026-03-31 |
| Deep Track Capital, LP | 2643542.00 | $21.49M | 3.0% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-19 | |
| Buy | null | 2026-08-17 | |
| Sell | null | 2026-06-18 | |
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-06-04 |
Back to KURA overview · KURA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.